Corton Capital’s Milestone Pharmaceuticals MIST Stock Holding History

Corton Capital’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-13,728	Closed	-$54.4K	–	364
2022 Q4	$54.4K	Buy	+13,728	New	+$72.3K	0.04%	290

Other funds holding MIST

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

AFA

Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Corton Capital's MIST Position: Q1 2023 in Review

Corton Capital sold out of Milestone Pharmaceuticals (MIST) in Q1 2023, closing a stake of 13,728 shares — an estimated $54.4K sold.

Corton Capital first reported a position in MIST in Q4 2022 and held it in 1 quarter. The position peaked at $54.4K in Q4 2022. 50 funds tracked by Wall St. Rank hold MIST as of Q1 2023.

Corton Capital reported no remaining Milestone Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Corton Capital sold 13,728 Milestone Pharmaceuticals shares in Q1 2023, an estimated $54.4K.
Corton Capital first reported a position in Milestone Pharmaceuticals in Q4 2022 and held it in 1 quarter.
Corton Capital's Milestone Pharmaceuticals position peaked at $54.4K in Q4 2022.
50 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2023.

Based on Corton Capital's 13F filing for Q1 2023, filed 15 May 2023.